Rhinovirus-induces progression of lung disease in a mouse model of COPD via IL-33/ST2 signaling axis

Rhinovirus (RV), which is associated with acute exacerbations, also causes persistent lung inflammation in patients with chronic obstructive pulmonary disease (COPD), but the underlying mechanisms are not well-known. Recently, we demonstrated that RV causes persistent lung inflammation with accumulation of a subset of macrophages (CD11b(+)/CD11c(+)), and CD8(+) T cells, and progression of emphysema. In the present study, we examined the mechanisms underlying the RV-induced persistent inflammation and progression of emphysema in mice with COPD phenotype. Our results demonstrate that at 14 days post-RV infection, in addition to sustained increase in CCL3, CXCL-10 and IFN-gamma expression as previously observed, levels of interleukin-33 (IL-33), a ligand for ST2 receptor, and matrix metalloproteinase (MMP) 12 are also elevated in mice with COPD phenotype, but not in normal mice. Further, MMP12 was primarily expressed in CD11b(+)/CD11c(+) macrophages. Neutralization of ST2, reduced the expression of CXCL-10 and IFN-gamma and attenuated accumulation of CD11b(+)/CD11c(+) macrophages, neutrophils and CD8(+) T cells in COPD mice. Neutralization of IFN-gamma, or ST2 attenuated MMP12 expression and prevented progression of emphysema in these mice. Taken together, our results indicate that RV may stimulate expression of CXCL-10 and IFN-gamma via activation of ST2/IL-33 signaling axis, which in turn promote accumulation of CD11b(+)/CD11c(+) macrophages and CD8+ T cells. Furthermore, RV-induced IFN-gamma stimulates MMP12 expression particularly in CD11b(+)/CD11c(+) macrophages, which may degrade alveolar walls thus leading to progression of emphysema in these mice. In conclusion, our data suggest an important role for ST2/IL-33 signaling axis in RV-induced pathological changes in COPD mice.